OUR TECHNOLOGY:

VERTAN TECHNOLOGIES: Building AI on the First Ever Patented Multi-Metal Nanoparticles

VerTan Technologies is developing a new AI platform, EurekaAI®, which will be trained to navigate the extensive and almost unlimited field of multi noble metal nanoparticles covered by our patent. This nanoparticle platform forms the foundation of our product development pipeline, which includes applications in cancer treatment, cosmetics, veterinary medicine, and more.

EurekaAI® will facilitate the candidate search process and significantly reduce the time needed for product selection, development, and formulation. Additionally, it will help identify the optimal applications for our technologies. VerTan’s nanoparticle technology is designed to combine noble metals in a proprietary way to enhance stability, biocompatibility, and activity. This platform can be used to precisely deliver a wide range of biologics and other cargo for targeted applications, improving efficacy and reducing side effects.

Product Formulation

Noble Metals:

Proprietarily combined to produce NobleFusion™ nanoparticles.

Coating:

Coated with Miramistin for stability, biocompatibility, and synergistic enhancement of activity.

Targeting and Cargo Loading:

Biologics and other cargo are loaded according to the desired application.

VerTan’s production approach promises a simplified design to lower costs and increase practicality, while delivering cutting-edge products.

AI based optimization

Leverage AI Technology:

Utilize existing AI frameworks or build an AI tailored to our specific needs.

Collecting Training Data:

Our Unique Datasets and all available information regarding noble metals, their structures, applications, and properties are used to train the AI engine.

AI Predictions:

Use the AI to predict optimal sub-platforms for desired applications based on the compiled data.

At VerTan Technologies, we believe in the predictive power of AI to save significant funds in future product development. Additionally, our ability to create custom products offers potential for additional revenue through licensing.

Expected Applications
Anti-Cancer

Promising Anti-Cancer Activity:

Our in vitro data indicated promising anti-glioblastoma and ovarian cancer activity of platinum-based NobleFusion™ nanoparticles.

Safer Alternatives:

Our technology rethinks highly toxic but effective anticancer drugs containing platinum (Pt) and ruthenium (Ru), providing safer, biocompatible, and efficacious synergistic alternatives.

Targeted Delivery:

Coupling cargo and biologics provides targeted delivery and an additional anti-cancer effect, further enhancing their action.

Miramistin Coating:

Miramistin not only lowers overall toxicity and potentiates the action but also synergistically provides antimicrobial action, which is often needed in cancer patients.

Our primary targets will be glioblastoma and ovarian cancer. However, we anticipate a much broader anticancer spectrum based on the similarity of anti-cancer mechanisms and the customization potential of our sub-platforms.

Anti-microbial: Human products, Veterinary and Agriculture

In Vitro Efficacy:

Our in vitro data explicitly showed that some of our NobleFusion™ sub-platforms have profound anti-microbial potential, even against antibiotic-resistant strains.

Resistance Prevention:


Due to the multi-targeted mode of action and historical data, we anticipate little or no resistance being acquired by microorganisms to our products.

Proven Success

Our first-generation silver-Miramistin nanoparticles were efficacious as veterinary and agricultural products, with excellent market adoption and efficacy. This next generation of products will enhance and broaden their activity.

Key Features:

Low toxicity, sustainability in production, and formulation are expected to be attractive features of our products.

It is now known that some noble metal nanoparticles can destroy certain viruses, such as SARS-CoV-2. Additionally, Miramistin has demonstrated anti-viral properties. The combination of these components in one entity is believed to generate a powerful human anti-viral drug. Considering the lack of effective antiviral drugs on the market and the growing demand for them, we believe this could become another potential application of one of our sub-platforms.

Cosmetics

Enhanced Penetration:

The use of NobleFusion™ nanoparticles allows for enhanced penetration and delivery of active ingredients into the deeper layers of the skin, improving efficacy and visible results. The penetration depth can be manipulated by adjusting the size of the nanoparticles.

Noble Metals:

Noble metals have been known for centuries for their beneficial effects in cosmetics. Many existing products contain nanoparticles, but combining two or more noble metals in one nanoparticle for enhanced synergistic action is a unique feature of VerTan Technologies.

Anti-Aging and Anti-Inflammatory Effects:

We believe significant anti-aging and anti-inflammatory effects can be achieved by using selected noble metals, particularly through their combinations.

Miramistin Benefits:

We believe significant anti-aging and anti-inflammatory effects can be achieved by using selected noble metals, particularly through their combinations.

  • Given the versatility of our technology, we anticipate broader applications in the cosmetic industry, including treatments for various skin conditions and enhancements in overall skin health. The growing demand for anti-aging and anti-inflammatory cosmetic products underscores the potential of our technology to meet market needs and drive innovation in the industry.tion in the industry.

vertantech© 2024